
Qianben Wang
Cancer Biology
RESEARCH FIELD
Cancer Biology
Prostate Cancer
Androgen Receptor Signaling
Transcription Factors
Chromatin/Epigenetic Regulation
Alternative Polyadenylation
CRISPR/Cas13 Gene Therapy
Education
Capital University of Medical Sciences, Beijing
B.S.
Clinical Medicine (B.Med.)
,
1994
University of Maryland School of Medicine
Ph.D
Physiology
,
2002
Summary
Qianben Wang is a cancer researcher who left Duke University, where he held the Banks Anderson, Sr. Distinguished Professorship in Pathology and was a member of the Duke Cancer Institute, to lead a major national research institute in China in 2025.
His laboratory focuses on the transcriptional and epigenetic mechanisms driving the progression of hormone-dependent cancers. His return reunites him in Beijing with his father, Wang Qi, an academician of the Chinese Academy of Engineering and renowned traditional Chinese medicine researcher, and his brother Wang Qianfei, a professor at the Beijing Institute of Genomics, Chinese Academy of Sciences. Their father gave both sons names meaning "to fly forward" and "to run forward" at birth, and their return has been described in Chinese media as the culmination of a multigenerational scientific family's journey.
CURRENT AFFILIATION
Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences / Peking Union Medical College
qianben@ibms.pumc.edu.cn







